Nynomic (M7U) investor relations material

Group overview and strategic direction

• Operates as a strategic financial holding with around 500 employees and a focus on optical metrology technologies.

• Pursues a buy-and-build strategy, achieving average annual revenue growth of 10% and focusing on global photonics industry consolidation.

• Comprises about 20 subsidiaries, with a strong presence in Europe, the USA, and Asia, and a particular focus on the US market.

• Integrates a growing portfolio of brands dedicated to non-contact, non-destructive optical measurement.

• Emphasizes vertical integration, offering solutions from components to complete systems.

Financial performance 2025 and Q1 2026

• 2025 revenue was €92.6 million, down 10% from the previous year, with EBIT dropping 73% to €2.0 million.

• EBIT margin fell to 2% in 2025, but the cost efficiency program NyFIT2025 generated sustainable annual savings of over €5 million.

• Q1 2026 saw revenue rise 8% year-over-year to €22.3 million, with EBIT turning positive at €0.1 million.

• Order backlog increased 23% in Q1 2026, reflecting robust demand and a book-to-bill ratio above one.

• Cash position at year-end 2025 was €14.5 million, with financial liabilities reduced by 37% to €3.1 million.

Market positioning and operational highlights

• Participated in major industry events, expanded AI-based solutions, and strengthened capital market presence through investor conferences.

• Enhanced efficiency through internal mergers and streamlined group structure, supporting operational performance.

• Focuses on innovation in precision agriculture, medical lab automation, and semiconductor production control.

• Leverages group synergies in sales, R&D, finance, marketing, IT, HR, and operations.

• Technologies address high-growth markets such as smart farming, smart industry, and high-speed data communication.